{"id":10070,"date":"2021-02-01T16:43:00","date_gmt":"2021-02-01T14:43:00","guid":{"rendered":"http:\/\/economic.karpat.in.ua\/?p=10070"},"modified":"2021-02-01T14:51:25","modified_gmt":"2021-02-01T12:51:25","slug":"az-eu-nak-szant-oltoanyag-mennyiseg-novelesere-keszul-a-biontech","status":"publish","type":"post","link":"https:\/\/economic.karpat.in.ua\/?p=10070&lang=hu","title":{"rendered":"Az EU-nak sz\u00e1nt olt\u00f3anyag-mennyis\u00e9g n\u00f6vel\u00e9s\u00e9re k\u00e9sz\u00fcl a BioNTech"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Az AstraZeneca ut\u00e1n a BioNTech is az Eur\u00f3pai Uni\u00f3nak sz\u00e1nt olt\u00f3anyag-sz\u00e1ll\u00edt\u00e1sainak n\u00f6vel\u00e9s\u00e9re k\u00e9sz\u00fcl, a n\u00e9met biotechnol\u00f3giai c\u00e9g h\u00e9tf\u0151i bejelent\u00e9se szerint a m\u00e1sodik negyed\u00e9vben ak\u00e1r 75 milli\u00f3val is t\u00f6bb adag \u00e9rkezhet a Pfizer amerikai gy\u00f3gyszeripari \u00f3ri\u00e1sc\u00e9ggel az \u00faj t\u00edpus\u00fa koronav\u00edrus (SARS-Cov-2) ellen kifejlesztett vakcin\u00e1jukb\u00f3l.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1000\" height=\"563\" src=\"http:\/\/economic.karpat.in.ua\/wp-content\/uploads\/2021\/02\/biontech.jpg\" alt=\"\" class=\"wp-image-10071\" srcset=\"https:\/\/economic.karpat.in.ua\/wp-content\/uploads\/2021\/02\/biontech.jpg 1000w, https:\/\/economic.karpat.in.ua\/wp-content\/uploads\/2021\/02\/biontech-300x169.jpg 300w, https:\/\/economic.karpat.in.ua\/wp-content\/uploads\/2021\/02\/biontech-768x432.jpg 768w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">N\u00e9met h\u00edrport\u00e1lokon ismertetett k\u00f6zlem\u00e9ny\u00e9ben a BioNTech p\u00e9nz\u00fcgyi \u00e9s \u00fcgyvezet\u0151 igazgat\u00f3ja, Sierk Poetting kifejtette, hogy befejezt\u00e9k a gy\u00e1rt\u00e1si kapacit\u00e1s n\u00f6vel\u00e9s\u00e9t szolg\u00e1l\u00f3 \u00e1talak\u00edt\u00e1st a Pfizer belgiumi \u00fczem\u00e9ben, \u00e9s a terveknek megfelel\u0151en halad az amerikai partnert\u0151l f\u00fcggetlen, n\u00e9metorsz\u00e1gi, marburgi \u00fczem\u00fck kialak\u00edt\u00e1sa. Az \u00faj gy\u00e1r beind\u00edt\u00e1s\u00e1hoz sz\u00fcks\u00e9ges enged\u00e9lyeket m\u00e1r beszerezt\u00e9k, a termel\u00e9s febru\u00e1rban elindulhat.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A v\u00e1llalat tov\u00e1bb dolgozik az\u00e9rt, hogy febru\u00e1r k\u00f6zep\u00e9t\u0151l ism\u00e9t t\u00f6bb olt\u00f3anyagot sz\u00e1ll\u00edthasson, \u00e9s \u00edgy marad\u00e9ktalanul teljes\u00edtse az EU-nak az els\u0151 negyed\u00e9vre tett szerz\u0151d\u00e9ses v\u00e1llal\u00e1sait. A kapacit\u00e1s jelent\u0151s b\u0151v\u00edt\u00e9se r\u00e9v\u00e9n az \u00e9v eg\u00e9sz\u00e9t tekintve a kor\u00e1bban \u00fctemezett 1,3 milli\u00e1rd helyett k\u00e9tmilli\u00e1rd adag olt\u00f3anyagot \u00e1ll\u00edthatnak el\u0151, \u00e9s az \u00e1prilis-j\u00faniusi id\u0151szakban a tervezettn\u00e9l ak\u00e1r 75 milli\u00f3val t\u00f6bb adagot sz\u00e1ll\u00edthatnak le az EU-tagorsz\u00e1goknak &#8211; \u00e1ll a k\u00f6zlem\u00e9nyben.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A Pfizer\/BioNTech vakcina volt az els\u0151, amelyre forgalmaz\u00e1si enged\u00e9lyt adtak ki az EU-ban. Az olt\u00e1sok bead\u00e1sa tavaly kar\u00e1csonykor kezd\u0151d\u00f6tt. A beszerz\u00e9seket a tagorsz\u00e1gok megb\u00edz\u00e1s\u00e1b\u00f3l int\u00e9z\u0151 Eur\u00f3pai Bizotts\u00e1g tavaly novemberben 300 milli\u00f3, janu\u00e1r elej\u00e9n tov\u00e1bbi 300 milli\u00f3 adag megv\u00e1s\u00e1rl\u00e1s\u00e1r\u00f3l k\u00f6t\u00f6tt szerz\u0151d\u00e9st a gy\u00e1rt\u00f3kkal.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Az Eur\u00f3pai Bizotts\u00e1g eln\u00f6ke, Ursula von der Leyen vas\u00e1rnap bejelentette, hogy az AstraZeneca is t\u00f6bb olt\u00f3anyagot biztos\u00edt a tagorsz\u00e1goknak. Az amerikai gy\u00f3gyszeripari c\u00e9g a kor\u00e1bbi terveiben szerepl\u0151 31 milli\u00f3 helyett 40 milli\u00f3 adagot sz\u00e1ll\u00edt az els\u0151 negyed\u00e9vben. A c\u00e9g azt is v\u00e1llalta, hogy sz\u00e1ll\u00edt\u00e1sait az eredeti menetrendhez k\u00e9pest egy h\u00e9ttel kor\u00e1bban elkezdi, \u00e9s b\u0151v\u00edti gy\u00e1rt\u00f3kapacit\u00e1s\u00e1t az EU-ban &#8211; ismertette a n\u00e9met politikus.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Az AstraZeneca term\u00e9ke az EU-ban a harmadik a SARS-Cov-2 elleni olt\u00f3anyagok sor\u00e1ban a Pfizer\/BioNTech \u00e9s az amerikai Moderna vakcin\u00e1ja ut\u00e1n. A br\u00fcsszeli bizotts\u00e1g 400 milli\u00f3 adag megv\u00e1s\u00e1rl\u00e1s\u00e1r\u00f3l k\u00f6t\u00f6tt szerz\u0151d\u00e9st a gy\u00e1rt\u00f3val, \u00e9s p\u00e9nteken adta ki a forgalmaz\u00e1si enged\u00e9lyt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">MTI<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Az AstraZeneca ut\u00e1n a BioNTech is az Eur\u00f3pai Uni\u00f3nak sz\u00e1nt olt\u00f3anyag-sz\u00e1ll\u00edt\u00e1sainak n\u00f6vel\u00e9s\u00e9re k\u00e9sz\u00fcl, a n\u00e9met biotechnol\u00f3giai c\u00e9g h\u00e9tf\u0151i bejelent\u00e9se szerint a m\u00e1sodik negyed\u00e9vben ak\u00e1r 75 milli\u00f3val is t\u00f6bb adag vakcina \u00e9rkezhet az EU-ba.<\/p>\n","protected":false},"author":10,"featured_media":10071,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41,1717,49],"tags":[6992,10503],"class_list":["post-10070","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cikkek","category-covid-19-hu","category-hirek","tag-koronavirus-vakcina","tag-vakcina-gyartas"],"_links":{"self":[{"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=\/wp\/v2\/posts\/10070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10070"}],"version-history":[{"count":0,"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=\/wp\/v2\/posts\/10070\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=\/wp\/v2\/media\/10071"}],"wp:attachment":[{"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economic.karpat.in.ua\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}